From Name:
From Email:
To Name:
To Email:

Optional Message:


First US patient treated with the Accu2i percutaneous microwave tissue ablation device

from BusinessWire via Benzinga

Microsulis Medical Limited, the leading company in microwave technology for medical devices, announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration clearance. The procedure involved a patient with hepatocellular carcinoma, or primary liver cancer, and was performed by N. Joseph Espat, Ph.D., professor and chief, surgical hepatobiliary oncology at Roger Williams Medical Center, Boston University. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063